Candel Therapeutics
Stock Forecast, Prediction & Price Target

Candel Therapeutics Financial Estimates

Candel Therapeutics Revenue Estimates

Candel Therapeutics EBITDA Estimates

Candel Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026
Revenue
 
% change YoY
$125K
 
N/A
$125K
 
0%
$0
 
-100%
Avg: $4.34M
Low: $4.34M
High: $4.34M
avg. 0%
Avg: $92.5M
Low: $92.5M
High: $92.5M
avg. 2027.32%
Net Income
 
% change YoY
$-36.17M
 
N/A
$-2.86M
 
92.07%
$-37.93M
 
-1223.76%
Avg: $-26.89M
Low: $-26.89M
High: $-26.89M
avg. 29.09%
Avg: $2.60M
Low: $2.60M
High: $2.60M
avg. 109.68%
EBITDA
 
% change YoY
$-24.41M
 
N/A
$-51.04M
 
-109.04%
$-37.43M
 
26.66%
Avg: $-2.60M
Low: $-2.60M
High: $-2.60M
avg. 93.03%
Avg: $-55.5M
Low: $-55.5M
High: $-55.5M
avg. -2027.32%
EPS
 
% change YoY
-$1.26
 
N/A
-$0.1
 
92.11%
-$1.31
 
-1217.90%
Avg: -$0.93
Low: -$0.93
High: -$0.93
avg. 29.03%
Avg: $0.09
Low: $0.09
High: $0.09
avg. 109.68%
Operating Expenses
 
% change YoY
$24.77M
 
N/A
$34.79M
 
40.46%
$14.41M
 
-58.58%
Avg: $226.75M
Low: $226.75M
High: $226.75M
avg. 1473.51%
Avg: $4.82B
Low: $4.82B
High: $4.82B
avg. 2027.32%

FAQ

What is Candel Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 69.39% in 2025-2026.

We have gathered data from 1 analysts. Their low estimate is -26.89M, average is -26.89M and high is -26.89M.

What is Candel Therapeutics stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 1013.66% in 2025-2026.

We have gathered data from 1 analysts. Their low revenue estimate is $4.34M, average is $4.34M and high is $4.34M.

What is Candel Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 69.35% in 2025-2026.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.93, average is -$0.93 and high is $-0.92.